Prodotti della ricerca

 

UNICA IRIS Institutional Research Information System

IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Cagliari dal mese di luglio 2015.

Mostra risultati da 1 a 20 di 93
successivo >
TitoloData di pubblicazioneAutore(i)RivistaEditore
Neuronal and peripheral damages induced by synthetic psychoactive substances: an update of recent findings from human and animal studies2020Costa, Giulia; De Luca, Maria Antonietta; Piras, Gessica; Marongiu, Jacopo; Fattore, Liana; Simol...a, NicolaNEURAL REGENERATION RESEARCH
Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (S)-CE-123 on Mesocorticolimbic Dopamine System2020Sagheddu, Claudia; Pintori, Nicholas; Kalaba, Predrag; Dragačević, Vladimir; Piras, Gessica; Lube...c, Jana; Simola, Nicola; De Luca, Maria Antonietta; Lubec, Gert; Pistis, MarcoBIOMOLECULES
The Role of Dopamine in the Stimulant Characteristics of Novel Psychoactive Substances (NPS)—Neurobiological and Computational Assessment Using the Case of Desoxypipradrol (2-DPMP)2020Loi, B.; Sahai, M. A.; De Luca, M. A.; Shiref, H.; Opacka-Juffry, J.FRONTIERS IN PHARMACOLOGY
The novel psychoactive substance methoxetamine induces persistent behavioral abnormalities and neurotoxicity in rats2019Costa, Giulia; Serra, Marcello; Pintori, Nicholas; Casu, Maria Antonietta; Zanda, Mary Tresa; Mur...tas, Daniela; De Luca, Maria Antonietta; Simola, Nicola; Fattore, LianaNEUROPHARMACOLOGY
Pharmacological and behavioral effects of the synthetic cannabinoid akb48 in rats2019Bilel, S.; Tirri, M.; Arfe, R.; Stopponi, S.; Soverchia, L.; Ciccocioppo, R.; Frisoni, P.; Strano...-Rossi, S.; Miliano, C.; De-Giorgio, F.; Serpelloni, G.; Fantinati, A.; De Luca, M. A.; Neri, M.; Marti, M.FRONTIERS IN NEUROSCIENCE
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans2019Leggio, G. M.; Torrisi, S. A.; Mastrogiacomo, R.; Mauro, D.; Chisari, M.; Devroye, C.; Scheggia, ...D.; Nigro, M.; Geraci, F.; Pintori, N.; Giurdanella, G.; Costa, L.; Bucolo, C.; Ferretti, V.; Sortino, M. A.; Ciranna, L.; De Luca, M. A.; Mereu, M.; Managò, F.; Salomone, S.; Drago, F.; Papaleo, F.MOLECULAR PSYCHIATRY
Editorial: Deconstructing the influence of genetic and age vulnerability to psychiatric disorders2019Cadoni, C.; De Luca, M. A.FRONTIERS IN PSYCHIATRY
Strategies of intervention to limit the novel synthetic opioids (NSO) escalation in Europe2019De Luca, M; Di Chiara, GRESEARCH AND ADVANCES IN PSYCHIATRY
Dopamine restores limbic memory loss, dendritic spine structure, and NMDAR-dependent LTD in the nucleus accumbens of alcohol-withdrawn rats2019Cannizzaro, Carla; Talani, Giuseppe; Brancato, ANNA MARIA; Mulas, Giovanna; Spiga, Saturnino; DE ...LUCA, MARIA ANTONIETTA; Sanna, Angela; Anna Maria Marino, Rosa; Diana, Marco; Biggio, G.; Sanna, E.THE JOURNAL OF NEUROSCIENCE
Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe2019Miliano, Cristina; Marti, Matteo; Pintori, Nicholas; Castelli, Maria Paola; Tirri, Micaela; Arfè,... Raffaella; De Luca, Maria AntoniettaFRONTIERS IN PHARMACOLOGY
The novel atypical dopamine uptake inhibitor (S)-CE-123 partially reverses the effort-related effects of the dopamine depleting agent tetrabenazine and increases progressive ratio responding2019Rotolo, R. A.; Dragacevic, V.; Kalaba, P.; Urban, E.; Zehl, M.; Roller, A.; Wackerlig, J.; Langer..., T.; Pistis, M.; De Luca, M. A.; Caria, F.; Schwartz, R.; Presby, R. E.; Yang, J. -H.; Samels, S.; Correa, M.; Lubec, G.; Salamone, J. D.FRONTIERS IN PHARMACOLOGY
Taste novelty and dopamine in Food Neophobia Behavioral and Biological Influences2018Bimpisidis, Zisis; Fattore, Liana; DE LUCA, MARIA ANTONIETTAElsevier Inc.
Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex2018Scheggia, D; Zamberletti, E; Realini, N; Mereu, M; Contarini, G; Ferretti, V; Managò, F; Margiani..., G; Brunoro, R; Rubino, T; De Luca, M A; Piomelli, D; Parolaro, D; Papaleo, FMOLECULAR PSYCHIATRY
Sales and advertising channels of new psychoactive substances (NPS): Internet, social networks, and smartphone apps2018Miliano, C; Margiani, G; Fattore, L; DE LUCA, MARIA ANTONIETTABRAIN SCIENCES
Loren Parsons' contribution to addiction neurobiology2018DE LUCA, MARIA ANTONIETTA; Buczynski, Mw; Di Chiara, G.ADDICTION BIOLOGY
Serotonergic signaling controls input-specific synaptic plasticity at striatal circuits2018Cavaccini, A; Gritti, M; Giorgi, A; Locarno, A; Heck, N; Migliarini, S; Bertero, A; Mereu, M; Mar...giani, G; Trusel, M; Catelani, T; Marotta, R; DE LUCA, MARIA ANTONIETTA; Caboche, J; Gozzi, A; Pasqualetti, M; Tonini, R.NEURON
Erratum to: Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment (Nature Communications, (2018), 9, 1, (2265), 10.1038/s41467-018-04711-w)2018Scheggia, D; Mastrogiacomo, R; Mereu, M; Sannino, S; Straub, Re; Armando, M; Managò, F; Guadagna,... S; Piras, F; Zhang, F; Kleinman, Je; Hyde, Tm; Kaalund, Ss; Pontillo, M; Orso, G; Caltagirone, C; Borrelli, E; DE LUCA, MARIA ANTONIETTA; Vicari, S; Weinberger, Dr; Spalletta, G; Papaleo, F.NATURE COMMUNICATIONS
Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment2018Scheggia, D.; Mastrogiacomo, R.; Mereu, M.; Sannino, S.; Straub, R. E.; Armando, M.; Manago, F.; ...Guadagna, S.; Piras, F.; Zhang, F.; Kleinman, J. E.; Hyde, T. M.; Kaalund, S. S.; Pontillo, M.; Orso, G.; Caltagirone, C.; Borrelli, E.; De Luca, M. A.; Vicari, S.; Weinberger, D. R.; Spalletta, G.; Papaleo, F.NATURE COMMUNICATIONS
Therapeutic Use of Synthetic Cannabinoids: Still an Open Issue?2018De Luca, M. A.; Fattore, L.CLINICAL THERAPEUTICS
Cannabis; epidemiological, neurobiological and psychopathological issues: an update2017DE LUCA, MARIA ANTONIETTA; DI CHIARA, Gaetano; Cadoni, Cristina; Lecca, Daniele; Orsolini, Laura;... Papanti, Duccio; Corkery, John; Schifano, FabrizioCNS & NEUROLOGICAL DISORDERS. DRUG TARGETS
   
credits unica.it | accessibilità Università degli Studi di Cagliari
C.F.: 80019600925 - P.I.: 00443370929
note legali | privacy

Nascondi la toolbar